Pathstone Holdings’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $531K | Sell |
2,200
-464
| -17% | -$112K | ﹤0.01% | 1697 |
|
|
2025
Q1 | $653K | Buy |
2,664
+284
| +12% | +$69.7K | ﹤0.01% | 1586 |
|
|
2024
Q4 | $782K | Buy |
2,380
+129
| +6% | +$42.4K | ﹤0.01% | 1489 |
|
|
2024
Q3 | $753K | Sell |
2,251
-119
| -5% | -$39.8K | ﹤0.01% | 1510 |
|
|
2024
Q2 | $647K | Sell |
2,370
-1,649
| -41% | -$450K | ﹤0.01% | 1558 |
|
|
2024
Q1 | $1.39M | Buy |
4,019
+1,300
| +48% | +$450K | 0.01% | 1081 |
|
|
2023
Q4 | $878K | Buy |
+2,719
| New | +$878K | ﹤0.01% | 1142 |
|